These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7634387)

  • 1. Quercetin not only inhibits P-glycoprotein efflux activity but also inhibits CYP3A isozymes.
    Sarkar MA
    Cancer Chemother Pharmacol; 1995; 36(5):448-50. PubMed ID: 7634387
    [No Abstract]   [Full Text] [Related]  

  • 2. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
    Bu HZ; Magis L; Knuth K; Teitelbaum P
    Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
    Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
    Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
    Shin SC; Choi JS; Li X
    Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase.
    Inaba T; Jurima M; Mahon WA; Kalow W
    Drug Metab Dispos; 1985; 13(4):443-8. PubMed ID: 2863108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
    Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
    Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic.
    Foster BC; Foster MS; Vandenhoek S; Krantis A; Budzinski JW; Arnason JT; Gallicano KD; Choudri S
    J Pharm Pharm Sci; 2001; 4(2):176-84. PubMed ID: 11466175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.
    Schuetz EG; Beck WT; Schuetz JD
    Mol Pharmacol; 1996 Feb; 49(2):311-8. PubMed ID: 8632764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors and inducers of CYP enzymes and P-Glycoprotein.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):e46-7. PubMed ID: 27027691
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction.
    Wang Y; Jiang YM; Wang YT; Kang JW; Yu T; Zhao HY; Bian BL; Huang M; Bi HC
    J Ethnopharmacol; 2014 Oct; 156():175-81. PubMed ID: 25219605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic exposure of Paracetamol (acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats and in vitro model: risk of liver toxicity.
    Pingili RB; Pawar AK; Challa SR
    Drug Dev Ind Pharm; 2015; 41(11):1793-800. PubMed ID: 25678313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisapride interaction with antidepressants.
    Caley C
    Ann Pharmacother; 1996 Jun; 30(6):684. PubMed ID: 8792962
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered cytochrome P450 and P-glycoprotein levels in rats during simulated weightlessness.
    Lu SK; Bai S; Javeri K; Brunner LJ
    Aviat Space Environ Med; 2002 Feb; 73(2):112-8. PubMed ID: 11846179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of chemicals as inhibitors of trout cytochrome P450s.
    Miranda CL; Henderson MC; Buhler DR
    Toxicol Appl Pharmacol; 1998 Feb; 148(2):237-44. PubMed ID: 9473531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.
    Desta Z; Soukhova NV; Flockhart DA
    Antimicrob Agents Chemother; 2001 Feb; 45(2):382-92. PubMed ID: 11158730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by allyl sulfides and phenethyl isothiocyanate of methyl-n-pentylnitrosamine depentylation by rat esophageal microsomes, human and rat CYP2E1, and Rat CYP2A3.
    Morris CR; Chen SC; Zhou L; Schopfer LM; Ding X; Mirvish SS
    Nutr Cancer; 2004; 48(1):54-63. PubMed ID: 15203378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P-450 as a target for therapeutic inhibitors.
    Mason JI
    Biochem Soc Trans; 1993 Nov; 21(4):1057-60. PubMed ID: 8131897
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes.
    Woodcroft KJ; Novak RF
    J Pharmacol Exp Ther; 1999 May; 289(2):1121-7. PubMed ID: 10215695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.
    Chua MS; Kashiyama E; Bradshaw TD; Stinson SF; Brantley E; Sausville EA; Stevens MF
    Cancer Res; 2000 Sep; 60(18):5196-203. PubMed ID: 11016648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
    Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
    Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.